Antimicrobial silver-coated tumor mega-endoprostheses;Antimikrobielle silberbeschichtung von tumorprothesen

Onkologe

Volumn 12, Issue 2, 2006, Pages 145-151

  Ahrens, H ^a,b   Gosheger, G ^a   Streitburger A ^a   Gebert, C ^a   Hardes, J ^a  

^a Klinik und Poliklinik für Allgemeine Orthopädie   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Antimicrobial effect; Infection prophylaxis; Silver coating; Tumor mega endoprostheses

Indexed keywords

ANTIINFECTIVE AGENT; SILVER;

ARTICLE; CANCER PATIENT; COATED PARTICLE; ENDOPROSTHESIS; HUMAN; INFECTION PREVENTION; SURGICAL MORTALITY; WOUND INFECTION;

EID: 32944471856     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-005-1007-1     Document Type: Article

References (24)

1. Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, Domann E, Schnettler R (2004) An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 25:4383-4391
2. Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, Scheddin D, Domann E, Schnettler R (2004) Nanoparticulate silver. A new antimicrobial substance for bone cement. Orthopade 33:885-892
3. Boosalis MG, McCall JT, Ahrenholz DH, Solem LD, McClain CJ (1987) Serum and urinary silver levels in thermal injury patients. Surgery 101:40-43
4. Brutel de la Riviere A, Dossche KM, Birnbaum DE, Hacker R (2000) First clinical experience with a mechanical valve with silver coating. J Heart Valve Dis 9:123-129 discussion 129-130
5. Capanna R, Morris HG, Campanacci D, Del Ben M, Campanacci M (1994) Modular uncemented prosthetic reconstruction after resection of tumours of the distal femur. J Bone Joint Surg Br 76:178-186
6. Chambers CW PC, Kabler PW (1962) Bactericidal effect of low concentrations of silver. J Am Water Works Assoc 54:208-216
7. Golubovich VN (1974) Toxic effect of silver ions on different groups of microorganisms. Mikrobiologiia 43:922-924
8. Gosheger G, Hardes J, Ahrens H et al. (2004) Silver-coated megaendoprostheses in a rabbit model - an analysis of the infection rate and toxicological side effects. Biomaterials 25:5547-5556
9. Greene RM, Su WP (1987) Argyria. Am Fam Physician 36:151-154
10. Gupta A, Matsui K, Lo JF, Silver S (1999) Molecular basis for resistance to silver cations in Salmonella. Nat Med 5:183-188
11. Ham SJ, Schraffordt Koops H, Veth RP, van Horn JR, Molenaar WM, Hoekstra HJ (1998) Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol 5:423-436
12. Koller J (2004) Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: a double-blind, clinical study. Drugs Exp Clin Res 30:183-190
13. Lansdown AB, Sampson B, Laupattarakasem P, Vuttivirojana A (1997) Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat. Br J Dermatol 137:728-735
14. Miller W (1889) Mikroorganismen der Mundhöhle. Verh Dtsch Odont Ges 1 (H. 2)
15. Nägeli CWv (1893) Über oligodynamische Erscheinungen in lebenden Zellen. Neue Denkschr Allgemein Schweiz Gesellsch Ges Naturweiss 33
16. Olson ME, Harmon BG, Kollef MH (2002) Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest 121:863-870
17. Schierholz JM, Beuth J, Pulverer G, Konig DP (1999) Silver-containing polymers. Antimicrob Agents Chemother 43:2819-2820 author reply 2820-2811
18. Sudmann E, Vik H, Rait M, Todnem K, Andersen KJ, Julsham K, Flesland O, Rungby J (1994) Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement. Med Prog Technol 20:179-184
19. Thiele H, Wolf K (1899) Arch Hyg 34
20. Tweden KS, Cameron JD, Razzouk AJ, Holmberg WR, Kelly SJ (1997) Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves. J Heart Valve Dis 6:553-561
21. von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2:677-685
22. Wan AT, Conyers RA, Coombs CJ, Masterton JP (1991) Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 37:1683-1687
23. Williams N, Gardner I (1995) Absence of symptoms in silver refiners with raised blood silver levels. Occup Med (Lond) 45:205-208
24. Zapata-Sirvent RL, Hansbrough JF (1993) Cytotoxicity to human leukocytes by topical antimicrobial agents used for burn care. J Burn Care Rehabil 14:132-140